• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M

cafead

Administrator
Staff member
  • cafead   Sep 23, 2024 at 11:42: AM
via After a series of trials and tribulations, Ventyx Biosciences has received a $27 million boost from Sanofi, money that is expected to extend the biotech’s cash runway into the second half of 2026.

article source